// App-Quantinova.ai

609 : Effect of Defibrotide on Kidney Ischemia Reperfusion Injury in a Preclinical Renal Transplant Model

Researchers

Presenter

  • P. Pine

Principal Investigators

  • Z. Sun

  • A. Matas

  • J. Shi

  • A. Ebrahimnejad

  • M. Zanette

  • P. Halloran

  • J. S. Bromberg

  • R. Hanvesakul

Medical Centers

  • Jazz Pharmaceuticals, Palo Alto, CA

  • Johns Hopkins Medicine, Baltimore, MD

  • University of Minnesota, Minneapolis, MN

  • Merck Pharmaceuticals, Philadelphia, PA

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • University of Maryland School of Medicine, Baltimore, MD

  • Jazz Pharmaceuticals,Oxford,United Kingdom

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Ischemia-reperfusion injury

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Defibrotide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved